• / Free eNewsletters & Magazine
  • / My Account

High Risk

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Ophthalmology Devices Market 2017: Analysis By Device Type & Geography - Research and Markets

    Global Ophthalmology Devices Market 2017: Analysis By Device Type & Geography - Research and Markets

  2. UPDATE: 7 questions bitcoin bulls need to answer now

    UPDATE: 7 questions bitcoin bulls need to answer now

  3. Kinnel: 4 High-Cost Fund Duds

    These funds are prime examples that costs are the best predictor of future performance.

  4. Transgene Presents First Clinical Data Indicating that TG1050 Induces a Robust and HBV-Specific Cell-Mediated Immune Response in Patients with Chronic Hepatitis B

    Transgene Presents First Clinical Data Indicating that TG1050 Induces a Robust and HBV-Specific Cell-Mediated Immune Response in Patients with Chronic Hepatitis B

  5. VALBIOTIS: LIPIDRIVE®: Efficacy Confirmed in Three Models, Finalization of Recruitment for Phase I/II in Humans

    VALBIOTIS: LIPIDRIVE®: Efficacy Confirmed in Three Models, Finalization of Recruitment for Phase I/II in Humans

  6. New Clinical Data Using the NvisionVLE® Imaging System to Be Presented at the World Congress of Gastroenterology @ ACG 2017 and UEGW 2017

    New Clinical Data Using the NvisionVLE® Imaging System to Be Presented at the World Congress of Gastroenterology @ ACG 2017 and UEGW 2017

  7. The Value of Liquidity

    Once you give it away, you can’t get it back, especially during a crisis.

  8. Philogen Announces Authorization from FDA of a Pivotal Registration Trial in USA for the Treatment of Resectable Melanoma

    Philogen Announces Authorization from FDA of a Pivotal Registration Trial in USA for the Treatment of Resectable Melanoma

  9. Putin, Russian central bank come down hard against bitcoin

    Putin, Russian central bank come down hard against bitcoin

  10. News Highlights: Top Company News of the Day

    News Highlights: Top Company News of the Day

12345

©2017 Morningstar Advisor. All right reserved.